Protalix BioTherapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.00B0.01B0.01B0.03B-0.00B0.00B0.00B0.01B0.02B0.03B0.05B0.06B0.04B0.05B0.07B0.05B
Cost of Revenue 0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.02B0.01B0.01B0.01B0.02B0.02B0.02B0.02B
Gross Profit -0.00B0.01B0.00B0.03B0.00B0.00B0.00B0.00B0.02B0.04B0.05B0.02B0.03B0.04B0.03B
Operating items
Research & Development 0.03B0.04B0.04B0.04B0.03B0.03B0.02B0.03B0.03B0.03B0.04B0.04B0.03B0.03B0.02B0.01B
Selling, General & Administrative 0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Other Operating Expenses 0.01B0.01B0.01B0.00B0.01B0.00B0.01B0.00B0.00B0.00B
Operating Expenses 0.03B0.04B0.04B0.05B0.04B0.04B0.03B0.04B0.04B0.04B0.05B0.05B0.04B0.04B0.03B0.03B
Operating Income -0.03B-0.03B-0.04B-0.01B-0.03B-0.03B-0.02B-0.03B-0.03B-0.02B-0.01B0.00B-0.02B-0.01B0.01B0.00B
EBIT -0.03B-0.03B-0.04B-0.01B-0.03B-0.03B-0.02B-0.03B-0.03B-0.02B-0.01B0.00B-0.02B-0.01B0.01B0.00B
Non-operating items
Interest & Investment Income -529.00
Other Non Operating Income 0.00B0.00B-0.01B-0.00B0.00B0.00B0.00B0.01B-0.04B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Non Operating Income 0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.05B-0.01B-0.01B-0.01B-0.01B-0.00B-0.00B0.00B
Net income details
EBT -0.03B-0.03B-0.04B-0.01B-0.04B-0.03B-0.03B-0.04B-0.04B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Tax Provisions 0.00B0.00B0.00B
Profit After Tax -0.03B-0.03B-0.04B-0.01B-0.03B-0.03B0.06B-0.03B-0.08B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Other Income 0.00B
Income from Continuing Operations -0.03B-0.03B-0.04B-0.01B-0.04B-0.03B-0.03B-0.04B-0.04B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Consolidated Net Income -0.03B-0.03B-0.04B-0.01B0.01B0.00B0.09B-0.00B-0.04B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Income towards Parent Company -0.03B-0.03B-0.04B-0.01B0.01B0.00B0.09B-0.00B-0.04B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Net Income towards Common Stockholders -0.03B-0.03B-0.04B-0.01B0.01B0.00B0.09B-0.00B-0.04B-0.03B-0.02B-0.01B-0.03B-0.01B0.01B0.00B
Additional items
EPS (Basic) 0.41-0.36-0.43-0.13-0.38-0.360.61-0.29-6.37-1.80-1.23-0.22-0.62-0.310.120.04
EPS (Weighted Average and Diluted) 0.000.00-1.23-0.22-0.62-0.310.090.04
Shares Outstanding (Weighted Average) 0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.03B0.05B0.05B0.07B0.07B
Shares Outstanding (Diluted Average) 76.94B80.96B0.01B0.03B0.04B0.05B
EBITDA -0.03B-0.03B-0.04B-0.01B-0.03B-0.03B-0.02B-0.03B-0.03B-0.02B-0.01B0.00B-0.02B-0.01B0.01B0.00B
Interest Expenses 0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.00B0.00B0.00B
Tax Rate 39.06%29.42%